For US residents only.

Financial Resources

TAFINLAR + MEKINIST

Novartis Pharmaceuticals Corporation offers several programs that can help patients with BRAF+ advanced melanoma receiving treatment with TAFINLAR® (dabrafenib) capsules + MEKINIST® (trametinib) tablets with access to treatment, as well as help eligible patients with out-of-pocket co-pay costs.

Novartis Oncology Universal Co-Pay Program

You may be eligible for immediate co-pay savings on your next prescription of TAFINLAR or MEKINIST.

  • Commercially insured individuals pay $10 per month for TAFINLAR or MEKINIST, or $20 per month for both products
  • Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*

* Limitations apply. Patient must have commercial insurance. Offer is not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full terms and conditions, visit www.CoPay.NovartisOncology.com or call 1-877-577-7756.

To find out if you are eligible for the Universal Co-Pay Program, call 1-877-577-7756 or visit www.CoPay.NovartisOncology.com.

Terms and Conditions: This offer is valid only for those with commercial insurance. Offer not valid under Medicare, Medicaid, or any other federal or state program. Not valid for cash payments, where product is not covered by patient’s commercial insurance, or where plan reimburses you for entire cost of your prescription drug. Offer is not valid where prohibited by law. Valid only in the United States and Puerto Rico. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. The card is the property of Novartis Pharmaceuticals Corporation and must be returned upon request. Novartis reserves the right to rescind, revoke, or amend this program without notice. Patient certifies responsibility for complying with applicable limitations, if any, of any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. This offer is subject to termination at any time. Additional Terms and Conditions may apply.

Patient Instructions: Present this offer and your insurance card along with a valid prescription at any participating pharmacy or through mail order. Patients with commercial insurance are responsible for $10 per 30 day supply for TAFINLAR or MEKINIST, or $20 for both products, and Novartis pays up to $15,000 per calendar year. If patient reaches the maximum annual cap per calendar year of $15,000, patient will be responsible for the difference. This offer is subject to termination at any time. Patient questions should be directed to 1-877-577-7756.

When you use this offer, you are certifying that you understand the program rules, regulations, and terms and conditions, and that you will disclose and report the use of this offer as may be required by your insurer. You are not eligible if prescriptions are paid by any federal or state program, or where prohibited by law; and you will otherwise comply with the terms and conditions above.

Free trial with Patient Assistance Now Oncology

With the Free Trial and Access Program, you can receive a free supply of TAFINLAR and MEKINIST for a US Food and Drug Administration–approved indication. The supply can be shipped directly to your home or another convenient location so you can start treatment immediately. Program rules may vary.

 

Ask your health care professional to help you apply for the PANO Free Trial and Access Program.

 

Our Patient Assistance Now Oncology (PANO) program was created to assist you with accessing your Novartis medicine(s)—from insurance verification to financial assistance—all through a knowledgeable and supportive call center.

 

 

Program overview

 

Novartis Oncology is committed to helping you get the Novartis medicine(s) you need. Access to medicine(s) can sometimes be difficult or confusing. PANO offers resources and support designed specifically to help make that process easier.

 

PANO can offer the following services:

  • Help with understanding your insurance coverage and financial responsibilities throughout the insurance verification process
  • Aid with identifying the pharmacies covered by your insurance plan
  • Insurance and Medicare education
  • Information about financial assistance that may be available
  • Patient Support Counselors who are able to provide information in over 160 languages
  • One single point of contact to help guide you through getting access to the Novartis medicine(s) prescribed by your doctor

To learn more, call 1-800-282-7630 or visit www.Patient.NovartisOncology.com.